MAY 2014

ryortho.com | 1-888-749-2153

Researchers at Baylor College of Medicine have identified a new ap-proach to treating osteogenesis imperfecta (OI), also known as brittle bone disease. Patients who have this congenital disorder live with fragile bones that break easily. The study, published in the current issue of the journal Nature Medicine, showed that excessive activity of an important sig-naling protein in the matrix of the bone called transforming growth factor beta is associated with the cause of the disease.

There are many genetic causes of brittle bone disease in children and adults, said Dr. Brendan Lee, professor of molecu-lar and human genetics at Baylor and a Howard Hughes Medical Institute inves-tigator, in the May 4, 2014 news release. We have discovered many of them but clinicians still cannot easily distinguish the different forms.

This identified an important concept in bone disease that while many differ-

ent genetic mutations can affect the pro-teins in the bone matrix (like collagen) they act in a common pathway to cause the bone diseasethat is they affect how signaling proteins called transforming growth factor beta (TGF) are delivered to cells in the bone. We now have a deeper understanding for how genetic mutations that affect collagen and collagen process-ing enzymes cause weak bones.

In animal studies, Dr. Lee and his col-leagues showed that blockade of the TGF proteins using an antibody could restore the quantity of bone in mice with differ-ent forms of brittle bone disease. Dr. Lee indicated that there are drugs in develop-ment to block this pathway in humans, so eventually the work can be translated into human studies, he said.

Dr. Lee told OTW, We plan to perform a clinical trial using anti-TGF antibod-ies in patients with severe brittle bone disease. It is going to be a phase I trial

focused on safety in OI patients. We will also assess effects on bone density and bone turnover markers.

New Treatment for Brittle Bone Disease

BY ELIZABETH HOFHEINZ, M.P.H., M.ED.

Orthopedics This Week is published 40 times a year by RRY Publications LLC, a subsidiary of Robin Young Consulting Group.116 Ivywood Lane, Wayne, PA 19087 1-888-749-2153 www.ryortho.com

Reprinted with permission of RRY Publications LLC Copyright 2014 RRY Publications LLC

Osteogenesis Imperfecta Type V in AdultWikimedia Commons and ShakataGaNai